Upgrade to SI Premium - Free Trial

KeyBanc: 'Three Key Takeaways from the Thermo Fisher Scientific (TMO) Investor Day'

May 26, 2026 8:53 AM
KeyBanc analyst Paul Knight reiterated an Overweight rating and $750.00 price target on Thermo Fisher Scientific (NYSE: TMO).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments